Literature DB >> 8780520

Scaffold/matrix-attached regions act upon transcription in a context-dependent manner.

D Schübeler1, C Mielke, K Maass, J Bode.   

Abstract

Scaffold/matrix-attached regions (S/MARs) are cis-acting elements with a function outside transcribed regions and in introns. Although they usually augment transcriptional rates, their action is highly context-dependent. We cloned an 800 bp S/MAR element from the upstream border of the human interferon-beta domain at various positions within a transcribed region of 4.3 kb. By use of retroviral gene transfer, the vector could be integrated into target cells as a single copy enabling a rigorous definition of the distance between the S/MAR and the transcriptional start site. At a distance of about 4 kb, the S/MAR supported transcriptional initiation, whereas at distances below 2.5 kb, transcription was essentially shut off. Controls proved the functionally of all constructs in the transient expression phase and ruled out any influence of S/MAR position on transcript stability. Moreover, no pausing or premature termination was observed within these elements. We suggest that the protein binding partners of S/MARs change according to the topological status, explaining these divergent S/MAR effects.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8780520     DOI: 10.1021/bi960930o

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  17 in total

1.  SUMO modification of a novel MAR-binding protein, SATB2, modulates immunoglobulin mu gene expression.

Authors:  Gergana Dobreva; Julia Dambacher; Rudolf Grosschedl
Journal:  Genes Dev       Date:  2003-12-15       Impact factor: 11.361

2.  Evaluation of sequence motifs found in scaffold/matrix-attached regions (S/MARs).

Authors:  I Liebich; J Bode; I Reuter; E Wingender
Journal:  Nucleic Acids Res       Date:  2002-08-01       Impact factor: 16.971

3.  Genome-wide in silico mapping of scaffold/matrix attachment regions in Arabidopsis suggests correlation of intragenic scaffold/matrix attachment regions with gene expression.

Authors:  Stephen Rudd; Matthias Frisch; Korbinian Grote; Blake C Meyers; Klaus Mayer; Thomas Werner
Journal:  Plant Physiol       Date:  2004-06       Impact factor: 8.340

4.  Performance of genomic bordering elements at predefined genomic loci.

Authors:  Sandra Goetze; Alexandra Baer; Silke Winkelmann; Kristina Nehlsen; Jost Seibler; Karin Maass; Jürgen Bode
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

5.  Nuclear matrix attachment regions of human papillomavirus type 16 repress or activate the E6 promoter, depending on the physical state of the viral DNA.

Authors:  W Stünkel; Z Huang; S H Tan; M J O'Connor; H U Bernard
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

6.  Strategies to insulate lentiviral vector-expressed transgenes.

Authors:  Ali Ramezani; Robert G Hawley
Journal:  Methods Mol Biol       Date:  2010

7.  Efficient episomal gene transfer to human hepatic cells using the pFAR4-S/MAR vector.

Authors:  Aristeidis Giannakopoulos; Michael Quiviger; Eleana Stavrou; Meletios Verras; Corinne Marie; Daniel Scherman; Aglaia Athanassiadou
Journal:  Mol Biol Rep       Date:  2019-04-12       Impact factor: 2.316

8.  Stimulation of Tat-independent transcriptional processivity from the HIV-1 LTR promoter by matrix attachment regions.

Authors:  Shravanti Rampalli; Asavari Kulkarni; Pavan Kumar; Devraj Mogare; Sanjeev Galande; Debashis Mitra; Samit Chattopadhyay
Journal:  Nucleic Acids Res       Date:  2003-06-15       Impact factor: 16.971

9.  Transgenic cattle produced by reverse-transcribed gene transfer in oocytes.

Authors:  A W Chan; E J Homan; L U Ballou; J C Burns; R D Bremel
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

10.  Locus control region elements HS1 and HS4 enhance the therapeutic efficacy of globin gene transfer in beta-thalassemic mice.

Authors:  Leszek Lisowski; Michel Sadelain
Journal:  Blood       Date:  2007-10-05       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.